Melanoma Program

The melanoma program at the University of Chicago provide state of the art clinical trials and leadership in national societies. They provide multidisciplinary exposure to melanoma including: novel clinical trials, immunotherapy and STING agonist, oncolytic herpes simplex viral therapies, minimally invasive node dissections and multidisciplinary tumor boards.